Future of the Global Genetic Testing Services Market: Growth Projections and Key Trends (2025-2034)

What are the recent trends in market size and growth for the genetic testing services market?

The genetic testing services market size has grown rapidly in recent years. It will grow from $19.19 billion in 2024 to $21.42 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing demand for personalized and precision medicine, growing prevalence of genetic disorders, high demand for prenatal testing during pregnancy, increasing population, and increased awareness and education.

The genetic testing services market size is expected to see rapid growth in the next few years. It will grow to $32.77 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to the growing demand for non-invasive prenatal testing (NIPT), the rise of pharmacogenomics, the growing focus on preventive healthcare, increasing direct-to-consumer (DTC) testing, and the focus on rare diseases and personalized therapies. Major trends in the forecast period include artificial intelligence (AI) and machine learning, advancements in user-friendly testing kits and online platforms, next-generation sequencing, microarray analysis, polymerase chain reaction (PCR), and advanced healthcare infrastructure.

Get Your Free Sample of The Global Genetic Testing Services Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15385&type=smp

Which major factors have contributed to the expansion of the genetic testing services market?

The increasing prevalence of genetic disorders is expected to propel the growth of the genetic testing services market going forward. Genetic disorders are conditions caused by abnormalities in an individual’s DNA, leading to physical or developmental abnormalities. The increasing prevalence of genetic disorders can be attributed to factors such as increased awareness, improved diagnostic techniques, expanded genetic screening, and the rising trend of consanguineous marriages in some populations. Genetic testing services are increasingly utilized in the diagnosis, prognosis, and treatment decision-making for individuals with genetic disorders, enabling personalized medical care and family planning strategies based on an individual’s genetic makeup. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. Moreover, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies are born with Down syndrome in the United States each year, which is about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the genetic testing services market.

How is the genetic testing services market segmented?

The genetic testing services market covered in this report is segmented –

1) By Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Other Types

2) By Disease: Cancer Disease, Metabolic Disease, Cardiovascular Disease, Other Diseases

3) By End User: Diagnostic Laboratories, Hospitals And Clinics, Academic Institutes And Research Centers, Other End Users

Subsegments:

1) By Predictive Testing: Cancer Predisposition Testing, Heart Disease Risk Testing, Neurological Disorder Risk Testing, Other Predictive Tests

2) By Carrier Testing: Carrier Screening For Single-Gene Disorders, Carrier Screening For Multifactorial Conditions, Carrier Screening For Inherited Genetic Conditions, Other Carrier Tests

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis, Chorionic Villus Sampling (CVS), Ultrasound-Combined Genetic Testing, Other Prenatal Tests

4) By Newborn Screening: Metabolic Disorder Screening, Genetic Disorder Screening, Hearing Loss Screening, Endocrine Disorder Screening, Other Newborn Screening Tests

5) By Other Types: Pharmacogenetic Testing, Forensic Genetic Testing, Ancestry And Genetic Genealogy Testing, Paternity Testing, Other Specialized Genetic Tests

Order your report now for swift delivery

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Who are the top competitors in the genetic testing services market?

Major companies operating in the genetic testing services market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, Agilent Technologies, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Holding Co, Berry Genomics Co. Ltd., Pacific Biosciences of California Inc., Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Blueprint Genetics Oy, Igenomix, Veritas Genetics

Which key trends are expected to influence the genetic testing services market in the coming years?

Major companies operating in the genetic testing services market are focusing on developing advanced technological solutions such as cancer screening tests, to enhance accuracy, expand testing capabilities, and improve overall patient outcomes. Cancer screening tests refer to routine, periodic tests conducted on individuals without symptoms to detect signs of cancer early. These tests aim to identify cancer or precancerous conditions before symptoms manifest, making treatment more effective. For instance, in June 2022, Prenetics Group Limited, a Hong Kong-based diagnostic and genetic testing company, launched ColoClear, a non-invasive stool DNA test in Hong Kong, which offers a highly sensitive screening method for detecting early signs of colorectal cancer. This innovative test combines advanced stool DNA technology with a fecal immunochemical test (FIT) to provide a convenient and effective alternative to colonoscopy. ColoClear has shown a sensitivity of 96% in detecting colorectal cancer and 64% in advanced adenoma detection in clinical studies.

Which regional trends are influencing the genetic testing services market, and which area dominates the industry?

North America was the largest region in the genetic testing services market in 2023. The regions covered in the genetic testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Genetic Testing Services Market Report 2025 Offer?

The genetic testing services market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Genetic testing services refers to analyzing an individual’s DNA to identify variations or mutations that could indicate disease risk, ancestry, or other genetic traits. These services typically offer insights into potential health conditions, ancestry, and personalized recommendations based on genetic predispositions, often facilitating informed medical decisions and lifestyle choices.

Purchase the exclusive report now to unlock valuable market insights:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15385

About The Business Research Company

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *